Seroprevalence of Dengue and Chikungunya Virus Antibodies, French Polynesia, 2014–2015

We investigated dengue and chikungunya virus antibody seroprevalence in French Polynesia during 2014–2015. Dengue virus seroprevalence was ≈60% among schoolchildren and >83% among the general population; chikungunya virus seroprevalence was <3% before and 76% after Zika virus emergence (2013)....

Descripción completa

Detalles Bibliográficos
Autores principales: Aubry, Maite, Teissier, Anita, Huart, Michael, Merceron, Sébastien, Vanhomwegen, Jessica, Mapotoeke, Mihiau, Mariteragi-Helle, Teheipuaura, Roche, Claudine, Vial, Anne-Laure, Teururai, Sylvianne, Sicard, Sébastien, Paulous, Sylvie, Desprès, Philippe, Manuguerra, Jean-Claude, Mallet, Henri-Pierre, Imrie, Allison, Musso, Didier, Deparis, Xavier, Cao-Lormeau, Van-Mai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2018
Materias:
Dispatch
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5823337/
https://www.ncbi.nlm.nih.gov/pubmed/29460745
http://dx.doi.org/10.3201/eid2403.171149
Descripción
Sumario:We investigated dengue and chikungunya virus antibody seroprevalence in French Polynesia during 2014–2015. Dengue virus seroprevalence was ≈60% among schoolchildren and >83% among the general population; chikungunya virus seroprevalence was <3% before and 76% after Zika virus emergence (2013). Dengue virus herd immunity may affect Zika virus infection and pathogenesis.

Ejemplares similares